SCHEMBL9822097

SCHEMBL9822097

COCc1nc2nc3c(c([S])n2n1)CCCC3

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.35
LMNA P02545 2/20 0.33
POLB P06746 1/20 0.31
HTR2C P28335 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9822181 0.97 LMNA (0.35) PKMLMNAPOLB
SCHEMBL9822104 0.84 PKM (0.36) PKMLMNAPOLBHTR2C
SCHEMBL9822255 0.82 LMNA (0.33) PKMLMNA
SCHEMBL9822171 0.81 PKM (0.35) PKMLMNAPOLB
SCHEMBL9822417 0.78 LMNA (0.35) PKMLMNAPOLB
SCHEMBL10408137 0.77 PKM (0.45) PKMLMNAPOLB
SCHEMBL10397427 0.76 LMNA (0.33) PKMLMNAPOLB
SCHEMBL9822120 0.72 PKM (0.38) PKM
SCHEMBL9822277 0.70 LMNA (0.39) PKMLMNAPOLB
SCHEMBL10698968 0.70 KDM4E (0.36) PKMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4987129-A BACTERICIDES SANKEI PHARMACEUTICAL CO., LTD. (JP) 1991-01-22 US disclosed
US-4958019-A Intermediates for synthesis of cephalosporin compounds SANKEI PHARMACEUTICAL CO., LTD. (JP) 1990-09-18 US disclosed
US-4956462-A Bactericides, ANTIBIOTICS, CEPHALOSPORINS SANKEI PHARMACEUTICAL CO., LTD. (JP) 1990-09-11 US disclosed
EP-0302633-A2 Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) 1989-02-08 EP disclosed